Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?

被引:1
|
作者
Eun, Chang Soo [1 ]
机构
[1] Hanyang Univ, Guri Hosp, Dept Internal Med, 153 Gyeongchun Ro, Guri 11923, South Korea
关键词
CROHNS-DISEASE; INFLIXIMAB;
D O I
10.5009/gnl16574
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
See "Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease" by So Yoon Choi, et al. on page 55, Vol. 11. No. 1, 2017
引用
收藏
页码:3 / 4
页数:2
相关论文
共 50 条
  • [1] Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease
    Frank I. Scott
    Gary R. Lichtenstein
    Current Treatment Options in Gastroenterology, 2014, 12 (1) : 59 - 75
  • [2] Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease
    van Hoeve, Karen
    Hoffman, Ilse
    Vermeire, Severine
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (02) : 185 - 196
  • [3] Efficacy of therapeutic drug monitoring of anti-TNF therapy in the control of patients with inflammatory bowel disease
    Bernardo, S.
    Fernandes, S.
    Goncalves, A. R.
    Baldaia, C.
    Valente, A.
    Moura Santos, P.
    Correia, L.
    Velosa, J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S308 - S309
  • [4] Is There a Role for Therapeutic Drug Monitoring of Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease
    Baert, Filip
    DIGESTIVE DISEASES, 2015, 33 : 70 - 77
  • [5] Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science?
    Samaan, Mark A.
    Arkir, Zehra
    Ahmad, Tariq
    Irving, Peter M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (12) : 1271 - 1279
  • [6] Therapeutic Drug Monitoring of the Infliximab (anti-TNF) Level with Bedside Kit in Inflammatory Bowel Disease
    Gur, M. B.
    Bakkaloglu, O. K.
    Eskazan, T.
    Akpinar, A.
    Hatemi, A., I
    Erzin, Y. Z.
    Celik, A. F.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1331 - i1331
  • [7] AN INDIAN NATIONAL SURVEY OF THERAPEUTIC DRUG MONITORING WITH ANTI-TNF MEDICATIONS IN INFLAMMATORY BOWEL DISEASE
    Nigam, Gaurav B.
    Patel, Rajan N.
    Jatale, Raj G.
    Makharia, Govind K.
    Ahuja, Vineet
    Desai, Devendra
    Limdi, Jimmy K.
    GASTROENTEROLOGY, 2020, 158 (06) : S246 - S246
  • [8] Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease
    Franca, Raffaella
    Curci, Debora
    Lucafo, Marianna
    Decorti, Giuliana
    Stocco, Gabriele
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (07) : 527 - 539
  • [9] Are We Ready for Proactive Therapeutic Drug Monitoring of Anti-TNF to Optimize Care of Patients With Inflammatory Bowel Disease?
    Charabaty, Aline
    CROHNS & COLITIS 360, 2020, 2 (01)
  • [10] Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases
    Felice, Carla
    Marzo, Manuela
    Pugliese, Daniela
    Papa, Alfredo
    Rapaccini, Gian Lodovico
    Guidi, Luisa
    Armuzzi, Alessandro
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (08) : 1107 - 1117